Harzke Amy Jo, Baillargeon Jacques, Paar David P, Pulvino John, Murray Owen J
Correctional Managed Care Division, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA.
Am J Gastroenterol. 2009 Jun;104(6):1412-9. doi: 10.1038/ajg.2009.106. Epub 2009 Apr 21.
Alcohol abuse and chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major etiologic factors for chronic liver disease/cirrhosis (CLD) in the United States. These CLD risk factors are highly prevalent in US adult incarcerated populations, but CLD-related mortality data from these populations are lacking. The primary objective of this study was to assess CLD-related mortality over time and across categories of race-ethnicity from 1989 through 2003 among male inmates in the Texas state prison system. The secondary objective was to examine patterns of recorded underlying, intervening, and contributing causes of death for CLD-related deaths.
Prisoner decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Deaths were considered CLD-related if CLD or common sequelae were recorded as the underlying, intervening, or contributing causes of death. CLD-related crude annual death rates, 5-year average annual death rates, and average annual percentage changes were estimated.
Among male Texas prisoners from 1989 to 2003, CLD-related deaths accounted for 16% of deaths (688/4,316). CLD-related crude annual death rates were high and increased over the study period by an average of 4.5% annually, with similar rate increases across categories of race-ethnicity. CLD-related average annual death rates were higher among Hispanic prisoners than among black prisoners in each 5-year period, and were higher than those for white prisoners in the 1994-1998 and 1999-2003 periods. HBV or HCV was identified as a causal factor in more than a third (34%) of CLD-related deaths.
From 1989 to 2003, CLD-related death rates among male Texas prisoners were high and increased over time, particularly among Hispanics. Targeted prevention, screening, and treatment of CLD risk factors, especially HCV, and early detection and treatment of CLD should be considered as priorities of the US prison healthcare systems.
在美国,酒精滥用以及慢性乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染是导致慢性肝病/肝硬化(CLD)的主要病因。这些CLD风险因素在美国成年在押人群中极为普遍,但缺乏来自这些人群的CLD相关死亡率数据。本研究的主要目的是评估1989年至2003年期间,得克萨斯州监狱系统男性囚犯中随时间推移以及不同种族/族裔类别中与CLD相关的死亡率。次要目的是研究CLD相关死亡的记录在案的潜在、中间和促成死因模式。
将囚犯死亡数据与得克萨斯州生命统计多死因数据相链接。如果CLD或常见后遗症被记录为死亡的潜在、中间或促成死因,则这些死亡被视为与CLD相关。估算了与CLD相关的粗年死亡率、5年平均年死亡率以及平均年变化百分比。
1989年至2003年期间,得克萨斯州男性囚犯中,与CLD相关的死亡占死亡总数的16%(688/4316)。与CLD相关的粗年死亡率很高,且在研究期间平均每年增加4.5%,不同种族/族裔类别的增长率相似。在每个5年期间,西班牙裔囚犯中与CLD相关的平均年死亡率高于黑人囚犯,并且在1994 - 1998年和1999 - 2003年期间高于白人囚犯。HBV或HCV被确定为超过三分之一(34%)的CLD相关死亡的病因。
1989年至2003年期间,得克萨斯州男性囚犯中与CLD相关的死亡率很高且随时间增加,尤其是在西班牙裔中。针对CLD风险因素,特别是HCV的有针对性的预防、筛查和治疗,以及CLD的早期检测和治疗应被视为美国监狱医疗系统的优先事项。